Osteoporosis is one of the most common skeletal disorders affecting a significant percentage of people worldwide. Research data suggested that systemic diseases such as osteoporosis could act as risk factors for osseointegration, jeopardizing the healing process and thus the predictability of dental implant success on compromised patients. It is well accepted that preclinical studies in animal models reproducing the osteoporotic condition are one of the most important stages in the research of new biomaterials and therapeutic modalities. The aim of this systematic review was to investigate whether osteoporosis compromises dental implant osseointegration in experimental osteoporotic-like conditions. A 3-stage systematic literature research was conducted in MEDLINE via OVID and EMBASE up to and including March 2017. Experimental studies reporting on dental implant osseointegration on different osteoporotic animal models were assessed. The studies had to report on the percentage of bone-to-implant contact (%BIC) as the primary outcome. ARRIVE guidelines for reporting on animal research were applied to evaluate the methodological quality and risk of bias of the studies. Fifty-seven studies met the inclusion criteria and were assessed qualitatively. The most adopted animal model was the rat. A variability of %BIC values was observed, ranging from 30% to 99% and from 26% to 94% for the healthy and osteoporotic group, respectively. The great majority (47) of the included studies concluded that estrogen deficiency significantly affects BIC values, 9 studies stated that it was not possible to observe statistical differences in BIC between ovariectomized and healthy groups and 1 study did not provide a comparison between the healthy and osteoporotic group. Owing to the great heterogeneity in implant surface, study design, observation time-points, site of implant placement and reported outcomes, a meta-analysis could not be performed. An overall high risk of bias was observed, owing to the limited information on animal housing and husbandry, baseline characteristics and health status, ethical statement and allocation to the experimental groups provided. Although the available studies seem to suggest a lower osseointegration in osteoporotic-like conditions, no robust conclusions can be drawn due to the great heterogeneity and overall low quality of the available studies.
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Future studies with emphasis on minimizing the possible sources of bias and evaluating osseointegration of dental implants placed into jawbones instead of long bones are warranted.
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| INTRODUC TI ON
Dental implants are considered an effective and reliable treatment modality for the functional and aesthetic rehabilitation of both partially and fully edentulous patients. 1 Clinical success of dental implants is based on the principle of osseointegration, which is defined as the anchorage of the implant surface in the surrounding bone. 2, 3 Osteoporosis is one of the most common skeletal disorders characterized by low bone mass and by an impairment of bone microarchitecture, with a consequent severe susceptibility towards bone fractures. 4, 5 According to the epidemiological data, the prevalence of the disease is constantly increasing and 35%-50% of women and 6%-20% of men older than 50 years are expected to confront a fracture related to osteoporosis within their lifetime. 6 Research data suggest that systemic diseases such as osteoporosis could jeopardize the bone healing process and thus the predictability of dental implants. [7] [8] [9] [10] In fact, osteoporotic bone cells present a decreased degree of proliferation, lower levels of transforming growth factor β1 production and a higher production of interleukin-6 compared to the osteoblasts derived from healthy subjects. 11 Furthermore, the number of mesenchymal stem cells with osteogenic potential decreases in osteoporotic conditions 12 and the analysis of bone specimens from osteoporotic patients revealed alterations in collagen stability, alignment and composition. [13] [14] [15] Taking all these findings under consideration, it is reasonable to speculate that osteoporosis may negatively affect dental implant osseointegration and the bone formation process.
Recently, our group has also shown that in osteoporotic-like conditions a trend towards an overexpression of proteins involved in stress and inflammatory response combined with a delayed/reduced recruitment and differentiation of osteoblast precursors should be expected. 16 On the other hand, other studies failed to find significant differences between healthy and ovariectomized animals. [17] [18] [19] Despite the large amount of available preclinical studies on dental implant osseointegration in osteoporotic animals, there is no thorough and updated systematic review summarizing the available evidence and providing indications for future research.
Hence, the aim of the current systemic review was to evaluate whether osteoporosis compromises dental implant osseointegration in experimental osteoporotic-like conditions and to assess the overall quality of the available studies. The findings of such a review would also determine the appropriate animal model and study design for future proof of principle studies testing new biomaterials, such as a new dental implant surface or bone substitutes, in osteoporotic-like condition.
| MATERIAL AND ME THODS

| Focused question
The question addressed was the following: "Does osteoporosis compromise the osseointegration of dental implants in experimental osteoporotic-like conditions?" Table S1 provides the details of the search strategy. An extensive hand search was also performed through the references listed in the included papers and other critical and systematic reviews on the topic. In an attempt to include also unpublished data, a specific theses database, www.
theses.com, was additionally screened and soon-to-be-published manuscripts were searched by contacting research groups with an interest in osteoporosis and dental implant outcomes. Finally, "Grey
Literature" was searched in opensigle.inist.fr.
A 3-stage screening was performed. All stages (titles, abstract, full-text) were carried out in duplicate and independently by 2 reviewers (X.D. and E.C.). The screening of the full-text articles was preformed, based on a specifically designed data extraction form for each article to confirm the eligibility of the study and collect relevant data. Reasons for study exclusion were also recorded. Any ambiguous or incomplete data were further investigated by contacting the researchers responsible for the work.
The level of agreement between the reviewers at each of the 3 stages of screening was calculated using kappa statistics. When a disagreement was raised, it was resolved by discussion and if consensus was not reached, a third experienced reviewer (N.M.) was consulted. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement 20 was followed.
Summary tables were created with the characteristics of the included studies. The similarities and the variations were assessed using a descriptive analysis.
| Outcome measures
| Primary outcome
The %BIC was defined as the relative amount (in %) of direct BIC to the total implant surface within an area of interest in osteoporotic-like animals compared to the %BIC in healthy animals. However, all other definitions of BIC were also considered.
| Secondary outcome
Mechanical test (eg, removal torque, pull-out, push-out) in osteoporotic-like compared to healthy animals.
| Methodological quality assessment and risk of bias
The methodological quality of the studies was assessed independently and in duplicate by 2 reviewers (X.D., E.C.), as part of the data extraction process and was based on the ARRIVE guidelines for reporting in vivo experiments in animal research. 21 The compliance with the ARRIVE guidelines of each of the included studies was evaluated using a predefined grading for the 20 categories.
22,23
| Data synthesis and statistical analysis
The BIC values were extracted from the studies meeting the inclusion and exclusion criteria and ranges were calculated for the different time-points and animal models. Owing to the significant heterogeneity in study methodology (eg, experimental models, observation times, implants), a meta-analysis could not be performed.
| RE SULTS
| Study selection
Fifty-seven studies met the defined inclusion criteria (Figure 1 ).
Thirty-four papers were excluded and the main reason for exclusion was the lack of BIC data. The details are presented in Table S2 . The kappa value for inter-reviewer agreement was .95 and .89 for titles and abstracts selection, respectively, thus indicating "very good" agreement, and 1 for full-text articles, thus indicating "perfect" 
| Study characteristics
The characteristics of the included studies are presented in Table S3a -c.
| Animal models
The number of animals used in the included studies varied between 10 and 224 animals.
The most common experimental model was the rat, which was used in 41 studies (71.93%). The age of the animals at osteoporosis induction was extremely heterogeneous, going from 30 days to 11 months, while in 1 study, the rats used were generically defined as adult, 25 and in another study, 26 the age of the rats was unclear.
Dental implants were placed in a period ranging between 21 and 182 days after osteoporosis induction in 82.9% of the included studies. In a few studies, implants were placed 56 days, 27 60 days, 28, 29 84 days 25 and 168 days 30 before osteoporosis induction, while in 2 studies, 25, 31 they were placed at the time of osteoporosis induction.
Only in 1 study, the time of implant placement was not clearly defined. 32 The implants were inserted mainly into the rat tibia (65.85%) or in the femur (19.5%). In 1 study, implants were placed into the medullary canal of the femur, 33 in 3 studies, they were placed into healed post-extraction sockets 29, 34, 35 and in 1 into the maxillary arch.
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Rabbits were used in 10 studies (17.54%) and in 60% of these studies, the age of the animals was between 4 and 12 months. In 2 studies, the animals are defined as either skeletally mature 37 or adult 38 and in another 2 studies, the age was unclear. 39, 40 Dental implants were placed 6-16 weeks after osteoporosis induction while in 3 studies the time of the placement was unclear. [37] [38] [39] [40] The implants have all been placed into the tibia with the exception of 1 study in which they have been placed into both the tibia and femur. 17 Sheep aged between 3 and 7 years were used in 5 studies (8.77%). The implants have been inserted into the tibia and femur 2 years after osteoporosis induction.
Finally, in 1 study, 16-week-old male senescence-accelerated prone mice and senescence-accelerated resistant mice were used and the implants were placed into both tibiae.
| Osteoporosis induction
Osteoporosis was mainly induced by ovariectomy (and orchidectomy in the case of male rats, in 1 study 41 ) (Table S3a -c). Osteoporosis was confirmed either by autopsy (ie, the absence of ovaries and atrophy of uterine horns) (rats), or by histological observation of the proximal tibial metaphyses (rats, rabbits), uterine horns (rats), iliac crest (sheep) and femur (rats), by monitoring the estrous cycle (rats), or by measuring the uterus weight (rats). In only 6 studies (rats, rabbits), the osteoporotic condition was assessed with bone mineral density (BMD) analyzed by dual-energy X-ray absorptiometry at either the long bones or the spine.
The effect of ovariectomy was evaluated by microcomputed tomography in 6 studies (rats) and the time period for the osteoporosis assessment condition ranged from 4 days to 6.5 months.
Finally, in 23 studies (40.35%), confirmation of osteoporosis was not reported or the details were unclear.
| Primary outcome (bone-to-implant contact)
In most of the studies, BIC or the osseointegrated implant surface, as it was referred in 1 study (rats), was calculated as the length percentage of the implant surface in direct contact with surrounding vital bone to the total implant surface. A different calculation of bone-toimplant contact implant, by using the diameter and not the length, was proposed by Cho et al 25 (rats).
Implant osseointegration was evaluated at different periods, ranging from 7 to 180 days for the rats, 2 to 18 weeks for the rabbits, 12 weeks for the sheep and 5 to 28 days for the mice.
The mean BIC (%) values reported are presented in Table S4a -c.
Forty-seven of the 57 included studies showed that estrogen deficiency significantly impairs BIC values and bone volume around the implant surface, while 9 studies stated that it was not possible to observe statistical differences in BIC between ovariectomized and healthy groups (rats, rabbits, sheep). 17, 18, 25, 29, 35, 37, [42] [43] [44] In 1 study, there was no comparison between the control and ovariectomy group (rats). 41 Furthermore, mechanical implant test (removal torque, push-out, pull-out) was performed in 36.84% of the studies. Data are presented in Table S4a -c.
| Implant characteristics
The great part of the studies employed titanium and titanium alloys implants, with the exception of 2 studies, 44, 45 where hydroxyapatite cylinder implants were placed in rats, and 1 study where stainless steel screws were placed in sheep. 46 The implants presented with either a non-coated or a coated surface. A great heterogeneity of coatings was noted through the studies, including implants coated with calcium phosphate nanoparticles (rats), implants coated with bisphosphonate (rats), with strontium (rats), collagen type I (rats) and hydroxyapatite, implants conditioned by a solution containing hydroxide ions, implants coated in a solution of collagen type I and chondroitin sulfate, implants coated with a simvastatin chitosan complex, and implants with a zoledronic acidstearate complex (rats). Further details on the implant surface are presented in Table S4a -c.
| Quality assessment and risk of bias
ARRIVE evaluation
Quality assessment of all included articles was performed based on the ARRIVE guidelines.
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The objectives of the study were clearly defined in 33 studies 
| D ISCUSS I ON
The present systematic review investigated whether osteoporosis compromises dental implant osseointegration. To the best of our knowledge, this is the first review to evaluate systematically the implant osseointegration in different osteoporotic animal models. The majority of the studies concluded that estrogen deficiency had a significant negative effect on BIC values and bone volume around the implants, thus potentially impairing the osseointegration process, while a limited number of studies underlined a non-statistically significant trend towards reduced BIC in ovariectomized compared to healthy animals (rats, rabbits, sheep).
Overall, ovariectomy alone or combined with corticosteroid treatment, low-calcium diet or nerve resection, was the most widely adopted method to induce an osteoporosis-like condition in rats, rabbits and sheep. It becomes evident from the methodology followed in the included studies that a standardized experimental model for the study of implants in the osteoporosis condition, in terms of age of the animals (some studies used growing animals, other skeletally mature animals), time between ovariectomy and experimental procedure and confirmation of osteoporosis induction, is not always followed and this may explain some discrepant results among the studies.
Ovariectomy induced bone loss does not occur in all bones, but it is rather a site-specific phenomenon, with the highest changes in BMD observed in long bones, followed by spine and ilium. 47 Therefore, the effect of experimental osteoporosis on implants placed in different skeletal sites might significantly differ. The difficulty in achieving an osteoporotic-like condition in the jaws of rodents has been highlighted in several publications. [48] [49] [50] Nevertheless, this issue might be successfully overcome by combining ovariectomy with either mechanical unloading 51 or low-calcium diet. 52 Only 4 studies evaluated implants placed in the jawbones, 29, [34] [35] [36] while in the remaining 53 studies long bones (tibia and femur) were considered. It has been pointed out that tibia in close proximity to the knee joint is characterized by the presence of trabecular bone, which potentially resembles the alveolar bone, while femur has a more pronounced cortical structure, 53 thus it may better resemble the mandible structure. Based on the available evidence, we therefore need to be cautious in drawing robust conclusions on the effect of osteoporosis on the osseointegration of dental implants placed into the jawbones.
Another important limitation to consider is that there is a different response to osteoporosis induction among different animal species, with different bone turnover rates at different skeletal sites, thus leading to potential differences in the BIC values. Most of the studies included in this review used rats and rabbits. Among rats,
Wistar and Sprague-Dawley strains were mainly used, potentially implying a variation in the results caused by the genetic heterogeneity. 54 Rats do not experience natural osteoporosis and it was claimed that bone changes after ovariectomy resemble rather osteopenia than osteoporosis. 54, 55 Furthermore, rat age and skeletal site used might influence the bone loss pattern leading to discrepancies in the results. According to Francisco et al, 56 24-week old rats are the animals that present the best osteoporotic response, while younger rats still show growth effect and might therefore not be suitable for osteoporosis research. Although rabbits show the least similarities to human bone, 57 they are still considered relevant for osteoporosis research. 58 Data show that bone micro-architecture and mineralization in ovariectomized rabbits after 4 weeks of glucocorticoid treatment were similar to osteoporosis-related changes in humans, while ovariectomy alone was not sufficient to induce osteoporosis. 58 In this review, in 4 of the 10 included studies on rabbits, ovariectomy was used alone to induce osteoporosis, thus raising potential concerns about the osteoporotic status of the animals.
Concerning the sheep experimental model, there is evidence showing that ovariectomy may not be sufficient to induce micro-architectural changes relevant to the biomechanical evaluation of osteoporosis in humans, 59 as the fast and significant bone reduction observed 3 months after ovariectomy is likely to be compensated at 12 months. 60 Therefore, the methodology followed by these studies may not have been appropriate to induce a successful osteoporotic-like condition. This could be a problem in the interpretation of the results, particularly in the cases where confirmation of osteoporosis was not reported.
Regarding the observation period, studies on the rat experimental model with more than 1 time-point of follow-up showed that BIC values are greater at the latest time-points, in both cortical and cancellous bone. Furthermore, in the majority of the studies using rabbits the researchers preferred 1 evaluation point at 3 months, when bone remodeling was already taking place. These data in conjunction with the suitable age of the animals could be useful for an appropriate design in future studies following the 3Rs' principle in terms of the reduction to the minimum number of animals used.
In the studies included in this review, a variety of titanium implants, with different surface characteristics was applied. It is well documented that dental implant surface characteristics play a decisive role in the osseointegration process. [61] [62] [63] [64] [65] [66] This is one of the main reasons why a meta-analysis was not performed, as it is meaningless to combine data on BIC coming from studies employing different implant surfaces. Nevertheless, and despite the different implant surfaces adopted, a common trend towards a reduced BIC in osteoporotic-like conditions was observed in the majority of the studies.
Finally, the experimental literature included in this review was considered overall of low quality, as the majority of the studies did not report data on housing and husbandry conditions, sample calculation, animal characteristics and implication of the 3Rs' principle.
In the future, a better compliance to methodology assessment tools such as ARRIVE 21 and SYRCLE's RoB (Risk of Bias) 67 will increase the reliability of the results and facilitate and improve critical appraisal of evidence from animal studies. [68] [69] [70] Recommendations for future preclinical in vivo studies on osteoporotic-like conditions should include: 
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